Catalyst Wire Dossier Catalyst Wire Dossier

Fludarabine/Cyclophosphamide

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fludarabine/Cyclophosphamide, covering 2016-07-25 to 2018-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma [Phase 2, Phase 3]

See pricing